Related Experiment Videos

Neuropeptide Y (NPY) as a tumor marker

T K Priø, E Hippe, N J Christensen

European Journal of Haematology

|October 1, 1993

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Demonstrated Benefit of Continuous Interferon-Alpha-2b Therapy in Hairy Cell Leukemia. A Two-Year Follow-Up.

Leukemia & lymphoma·2016

An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.

European journal of cancer (Oxford, England : 1990)·2007

Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support.

Medical oncology (Northwood, London, England)·2002

Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group.

European journal of haematology·2000

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.

Blood·1999

Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life.

British journal of haematology·1999

See all related articles